S. 1666 · 108th Congress
Diabetes Prevention and Treatment Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
CochranSponsor16 cosponsors · 15 D, 1 R
D
Kennedy
LG
R
Graham
JL
D
Lieberman
CD
D
Dodd
JB
D
Bingaman
TD
D
Daschle
JK
D
Kerry
FL
D
Lautenberg
JC
D
Corzine
TC
D
Carper
CS
D
Schumer
DI
D
Inouye
TJ
D
Johnson
HR
D
Reid
ML
D
Landrieu
BB
D
Boxer1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Diabetes Prevention and Treatment Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control (CDC), to award grants to support comprehensive State diabetes control and prevention programs.
What it does: CRS summary · Introduced in Senate · Sep 26, 2003
Diabetes Prevention and Treatment Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control (CDC), to award grants to support comprehensive State diabetes control and prevention programs.
Requires the Secretary to promote and coordinate diabetes research, including data collection and the development of best practices, early detection and prevention programs, and a national diabetes laboratory.
Gives priority to programs which reduce disparities in diabetes prevention and care for high-risk or underserved populations.
Requires the Secretary, acting through the Director, to award competitive grants to apply the best practices identified by the Secretary for diabetes prevention and control. Gives priority to programs to reduce disparities in prevention and control for high-risk or underserved populations.
Requires the Director to: (1) develop and update scientifically validated quality measures for assessing and improving clinical services related to diabetes; (2) establish a Diabetes Quality Improvement Program; and (3) incorporate diabetes in the annual quality and disparities reports.
Directs the Secretary, acting through the Diabetes Mellitus Interagency Coordinating Committee, to: (1) coordinate a national diabetes education program; and (2) develop and update a strategic research plan for diabetes.
Requires the expansion of research programs concerning diabetes in underserved populations and minority groups and in children and youths.
Requires the development or enhancement of data collection on the prevalence of type 1 and type 2 diabetes in children, including the support of long-term epidemiological studies in children.
Authorizes a report on diabetes by the Surgeon General.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Diabetes Prevention and Treatment Act
Latest action (Sep 26, 2003): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Sep 26, 2003
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.